Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Beginning Cash Balance: 2012-2025

Historic Beginning Cash Balance for Phibro Animal Health (PAHC) over the last 14 years, with Jun 2025 value amounting to $70.6 million.

  • Phibro Animal Health's Beginning Cash Balance fell 3.65% to $68.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.8 million, marking a year-over-year increase of 20.12%. This contributed to the annual value of $70.6 million for FY2025, which is 71.05% up from last year.
  • According to the latest figures from FY2025, Phibro Animal Health's Beginning Cash Balance is $70.6 million, which was up 71.05% from $41.3 million recorded in FY2024.
  • In the past 5 years, Phibro Animal Health's Beginning Cash Balance ranged from a high of $74.2 million in FY2023 and a low of $36.3 million during FY2021.
  • Its 3-year average for Beginning Cash Balance is $62.0 million, with a median of $70.6 million in 2025.
  • In the last 5 years, Phibro Animal Health's Beginning Cash Balance plummeted by 44.40% in 2024 and then soared by 71.05% in 2025.
  • Over the past 5 years, Phibro Animal Health's Beginning Cash Balance (Yearly) stood at $36.3 million in 2021, then skyrocketed by 38.16% to $50.2 million in 2022, then skyrocketed by 47.87% to $74.2 million in 2023, then tumbled by 44.40% to $41.3 million in 2024, then surged by 71.05% to $70.6 million in 2025.